Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy

[Display omitted] •Dysregulated Wnt/β-catenin signaling causes many diseases, such as cancer, renal disease and bone disorders.•Natural small molecules have targeted therapeutic effects on dysregulated Wnt/β-catenin signaling pathway.•Wnt/β-catenin signaling pathway is promising targets for natural...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2019-09, Vol.117, p.108990-108990, Article 108990
Hauptverfasser: Liu, Dan, Chen, Lin, Zhao, Hui, Vaziri, Nosratola D., Ma, Shuang-Cheng, Zhao, Ying-Yong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Dysregulated Wnt/β-catenin signaling causes many diseases, such as cancer, renal disease and bone disorders.•Natural small molecules have targeted therapeutic effects on dysregulated Wnt/β-catenin signaling pathway.•Wnt/β-catenin signaling pathway is promising targets for natural small molecules. The Wnt/β-catenin signaling pathway is an evolutionarily conserved developmental signaling event that plays a critical role in regulating tissue development and maintaining homeostasis, the dysregulation of which contributes to various diseases. Natural products have been widely recognized as a treasure trove of novel drug discovery for millennia, and many clinical drugs are derived from natural small molecules. Mounting evidence has demonstrated that many natural small molecules could inhibit the Wnt/β-catenin pathway, while the efficacy of natural products remains to be determined. Therefore, this paper primarily reviews the targeting mechanism of natural small molecules for aberrant Wnt/β-catenin pathway that is intimately implicated in the pathogenesis of myriad diseases, such as cancers, renal diseases, neurodegenerative diseases and bone disorders. In addition, this review also highlights some natural products that have the potential to halt Wnt/β-catenin pathway, especially for porcupine, the receptors of Wnt ligands, β-catenin and β-catenin-dependent proteins. Additionally, a series of natural small molecules have shown good therapeutic effects against mutations of the Wnt/β-catenin pathway, which may dramatically facilitate the development of natural products in Wnt/β-catenin pathway intervention.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2019.108990